$17 million in Series A investment was secured by Acclinate, a Birmingham, AL-based business that specializes in energizing diverse communities for improved health equity.
Investors
- Cencora Ventures
- Labcorp and Latimer Ventures
Use of funds
With the money, the business hopes to increase the scope of its influence in the areas of clinical trial diversity and health equity.
“With the support of notable healthcare organizations like Cencora and Labcorp, we are poised to accelerate tangible change in the healthcare industry and empower diverse communities to proactively manage their health.”
Del Smith
About Acclinate
Acclinate is a digital health startup led by CEO Del Smith that uses predictive analytics in conjunction with ongoing community participation to increase health equality. Through its community platform, pharmaceutical firms may encourage inclusion in their projects and other healthcare organizations can boost diversity in their clinical trials.
